References
- Champlin R., Gale R. P. Acute Lymphoblastic Leukemia: Recent Advance in Biology and Therapy. Blood 1989; 73: 2051–2066
- Gaynor J., Chapman D., Little C., et al. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital Experience since 1969. J. Clin. Oncol. 1988; 6: 1014–1030
- Hoelzer D., Thiel E., Löffler H., et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–131
- Linker C. A., Levitt L. J., O'Donnell M., et al. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 1991; 78: 2814–2822
- Marie J. P., David B., Tulliez M., et al. Leucemie aiguë lymphoblastique de l'adulte: évaluation précoce de la réponse au traitement: étude de la décroissance blastique sanguine et modullaire. Nouv. Presse Med. 1982; 11: 505–507
- Miller D. R., Coccia P. F., Bleyer W. A., et al. Early response to induction therapy as a predictor of disease-free survival and late reccurence of childhood acutelympho-blastic leukemia: report from the childrens cancer study group. J. Clin. Oncol. 1989; 7: 1807–1815
- Miller D. R., Leikin S., Albo V., et al. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. Cancer 1983; 51: 1041–1049
- Rautonen J., Hovi L., Siimes M. A. Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood 1988; 71: 989–991
- Bennett J. M., Catovsky D., Daniel M. T., et al. Proposals for classification of acute leukaemias. Br. J. Haematol. 1976; 33: 451–458
- Stryckmans P., De Witte Th., Marie J. P., et al. Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). Leukemia 1992; 6(Suppl. 2)199–203
- Baccarani M., Corbelli G., Amadori S., et al. Adolescent and adult acute lymphoblastic leukemia: Prognostic feature and outcome of therapy. A study of 293 patients. Blood 1982; 60: 677–684
- Hussein K. K., Dahlberg S., Head D., et al. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood 1989; 73: 57–63
- Leimert J. T., Burns C. P., Wiltse C. G., et al. Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. Blood 1980; 56: 510–515
- Linker C. A., Levitt L. J., O'Donnell M., et al. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 1987; 69: 1242–1248
- Barnett M. J., Greaves M. F., Amess J. A., et al. Treatment of acute lymphoblastic leukemia in adults. Br. J. Haematol. 1986; 64: 455–468
- Radford J. E., Jr, Burns C. P., Jones M. P., et al. Adult acute lymphoblastic leukemia: Result of the Iowa HOP-L protocol. J. Clin. Oncol. 1989; 7: 58–66
- Gingrich R. D., Burns P., Armitage J. O., et al. Long-term relapse-free survival in adult acute lymphoblastic leukemia. Cancer Treat. Rep. 1985; 69: 153–160
- Ellison R. R., Mick R., Cuttner J., et al. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphoblastic leukemia: a prospective randomized clinical trial by cancer and leukemia group B. J. Clin. Oncol 1991; 9: 2002–2015
- Strykmans P., Marie J. P., Suciu S., et al. Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and acute consolidation therapies, preliminary results of EORTC study 58791
- Bloomfield C. D., Goldman A. I., Alimena G., et al. Chromosomal abnormalities identify high-risk and low-risk patient with acute lymphoblastic leukemia. Blood 1986; 67: 415–420
- Niederwieser D., Granena A., Hermans J., et al. Slow response to induction chemotherapy is an indicator of poor survival after bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 1992; 9: 439–443
- Riehm H., Feickert H. J., Scharppe M., . Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. Acute leukemias: prognostic factors and treatment strategies, T. Buchner, G. Schellong, W. Hiddemann, D. Urbanitz, J. Ritter, et al. Springer-Verlag, Berlin 1987; 139–146
- Pieters R., Huismans D. R., Loonen A. H., et al. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 1991; 338: 399–403